QE3 Euphoria Keeps Markets on Upward Path

Markets were still in a state of quantitative-easing inspired euphoria today, a day after the Fed announced its latest bond-buying program. The Dow Jones Industrial Average (INDEX: ^DJI) is up 0.3%, while the S&P 500 (INDEX: ^GSPC) has risen 0.4% in trading today.

Stocks tied to commodities are leading the way, with Alcoa (NYS: AA) up 2.4% and Caterpillar up 2.6% with a half-hour left in the trading day. Copper, silver, and oil are all up on hopes that QE will rev up the economy and boost demand. Ironically, the increase in commodity prices will hurt the economy for a variety of reasons, so these stocks may not benefit from QE3 after all.

Gold is also up -- no surprise, as it's been driven higher by the Fed's "money-printing" campaign.

Pharmaceutical stocks led the decliners today. Pfizer (NYS: PFE) is down 1.9% in late trading, and Merck (NYS: MRK) is down 2.2%, but there isn't much explanation for the big move. Pharma companies won't get the same bounce as financials or infrastructure companies from stimulus, so I guess it's something of a risk-on trade today.

The rally in the past week has been fueled by central banks, and I'm a bit skeptical it will lead to the kind of results the market is evidently hoping for. All of the economic news is pointing to a pretty slow recovery, and with commodity prices moving higher, I'm not sure how that helps the middle class get out of its funk.

The article QE3 Euphoria Keeps Markets on Upward Path originally appeared on Fool.com.

Fool contributor Travis Hoium does not have a position in any company mentioned. You can follow Travis on Twitter at @FlushDrawFool, check out his personal stock holdings or follow his CAPS picks at TMFFlushDraw.The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.